首页> 外文OA文献 >Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting
【2h】

Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting

机译:使用Dielectrophoretic细胞分选从CellSearch富集的血液样本中半自动分离单个或高度纯化的肿瘤细胞并进行分子表征

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background:Molecular characterisation of single circulating tumour cells (CTCs) holds considerable promise for predictive biomarker assessment and to explore CTC heterogeneity. We evaluate a new method, the DEPArray system, that allows the dielectrophoretic manipulation and isolation of single and 100% purified groups of CTCs from pre-enriched blood samples and explore the feasibility of their molecular characterisation.Methods:Samples containing known numbers of two cell populations were used to assess cell loss during sample loading. Cultured breast cancer cells were isolated from spiked blood samples using CellSearch CTC and Profile kits. Single tumour cells and groups of up to 10 tumour cells were recovered with the DEPArray system and subjected to transcriptional and mutation analysis.Results:On average, 40% cell loss was observed when loading samples to the DEPArray system. Expected mutations in clinically relevant markers could be obtained for 60% of single recovered tumour cells and all groups of tumour cells. Reliable gene expression profiles were obtained from single cells and groups of up to 10 cells for 2 out of 3 spiked breast cancer cell lines.Conclusion:We describe a semiautomated workflow for the isolation of small groups of 1 to 10 tumour cells from whole blood samples and provide proof of principle for the feasibility of their comprehensive molecular characterisation.British Journal of Cancer advance online publication, 7 March 2013; doi:10.1038/bjc.2013.92 www.bjcancer.com.
机译:背景:单个循环肿瘤细胞(CTC)的分子表征在预测生物标志物评估和探索CTC异质性方面具有广阔的前景。我们评估了一种新的方法DEPArray系统,该系统允许通过双电泳操作和从预富集血样中分离出单个和100%纯化的四氯化碳组,并探索其分子表征的可行性。方法:包含已知数量的两个细胞的样品群体用于评估样品上样期间的细胞损失。使用CellSearch CTC和Profile试剂盒从加标的血液样本中分离出培养的乳腺癌细胞。用DEPArray系统回收单个肿瘤细胞和多达10个肿瘤细胞的组,并进行转录和突变分析。结果:将样品加载到DEPArray系统中时,平均观察到40%的细胞损失。可以为60%的单个回收肿瘤细胞和所有肿瘤细胞组获得预期的临床相关标记突变。从3个掺入的乳腺癌细胞系中的2个中,从单个细胞和多达10个细胞的组中获得可靠的基因表达谱。结论:我们描述了一种半自动化工作流程,用于从全血样品中分离1至10个小组的肿瘤细胞《英国癌症杂志》在线提前发表,2013年3月7日;并提供了对其进行全面分子表征的可行性的原理证明。 doi:10.1038 / bjc.2013.92 www.bjcancer.com。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号